276 related articles for article (PubMed ID: 16204339)
1. Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Sakka V; Galani L; Pefanis A; Iliopoulos D; Athanasopoulos G; Donta I; Giamarellou H
J Antimicrob Chemother; 2005 Dec; 56(6):1160-2. PubMed ID: 16204339
[TBL] [Abstract][Full Text] [Related]
2. Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.
Athanassopoulos G; Pefanis A; Sakka V; Iliopoulos D; Perrea D; Giamarellou H
Antimicrob Agents Chemother; 2006 Feb; 50(2):654-7. PubMed ID: 16436723
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Galani L; Pefanis A; Sakka V; Iliopoulos D; Donta I; Triantafyllidi H; Skiadas I; Karayiannakos P; Giamarellou H
Int J Antimicrob Agents; 2009 Jan; 33(1):65-9. PubMed ID: 18818055
[TBL] [Abstract][Full Text] [Related]
4. Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Katsarolis I; Pefanis A; Iliopoulos D; Siaperas P; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2000 Sep; 44(9):2564-6. PubMed ID: 10952619
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.
Skiadas I; Pefanis A; Papalois A; Kyroudi A; Triantafyllidi H; Tsaganos T; Giamarellou H
Antimicrob Agents Chemother; 2007 Aug; 51(8):2848-54. PubMed ID: 17562794
[TBL] [Abstract][Full Text] [Related]
6. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.
Perdikaris GS; Pefanis A; Giamarellou H; Nikolopoulos A; Margaris EP; Donta I; Tsitsika A; Karayiannakos P
Antimicrob Agents Chemother; 1997 Sep; 41(9):1916-21. PubMed ID: 9303384
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis.
Sipahi OR; Turhan T; Pullukcu H; Calik S; Tasbakan M; Sipahi H; Arda B; Yamazhan T; Ulusoy S
J Antimicrob Chemother; 2008 Mar; 61(3):670-3. PubMed ID: 18230687
[TBL] [Abstract][Full Text] [Related]
9. Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique.
Sanioğlu S; Sokullu O; Yavuz SS; Kut MS; Palaz FK; Bilgen FS
Anadolu Kardiyol Derg; 2008 Feb; 8(1):79-80. PubMed ID: 18258545
[No Abstract] [Full Text] [Related]
10. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
13. Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.
Sakalar YB; Ozekinci S; Celen MK
J Ocul Pharmacol Ther; 2011 Dec; 27(6):593-8. PubMed ID: 21834669
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ
Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862
[TBL] [Abstract][Full Text] [Related]
15. Development of a mouse model of induced Staphylococcus aureus infective endocarditis.
Gibson GW; Kreuser SC; Riley JM; Rosebury-Smith WS; Courtney CL; Juneau PL; Hollembaek JM; Zhu T; Huband MD; Brammer DW; Brieland JK; Sulavik MC
Comp Med; 2007 Dec; 57(6):563-9. PubMed ID: 18246868
[TBL] [Abstract][Full Text] [Related]
16. High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.
Murillo O; Pachón ME; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Gudiol F; Ariza J
J Infect; 2009 Mar; 58(3):220-6. PubMed ID: 19217166
[TBL] [Abstract][Full Text] [Related]
17. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
Piercy T; Steward J; Lever MS; Brooks TJ
J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.
Vehreschild JJ; Moritz G; Vehreschild MJ; Arenz D; Mahne M; Bredenfeld H; Chemnitz J; Klein F; Cremer B; Böll B; Kaul I; Wassmer G; Hallek M; Scheid C; Cornely OA
Int J Antimicrob Agents; 2012 Feb; 39(2):130-4. PubMed ID: 22169408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
